Edition:
United Kingdom

Nichi-Iko Pharmaceutical Co Ltd (4541.T)

4541.T on Tokyo Stock Exchange

1,727JPY
12:18am GMT
Change (% chg)

¥-2 (-0.12%)
Prev Close
¥1,729
Open
¥1,721
Day's High
¥1,731
Day's Low
¥1,715
Volume
45,700
Avg. Vol
382,148
52-wk High
¥1,895
52-wk Low
¥1,598

Latest Key Developments (Source: Significant Developments)

Nichi-Iko Pharmaceutical to start sales of Infliximab BS for I.V. Infusion 100mg "Nichi-Iko"
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Nichi-Iko Pharmaceutical Co Ltd <4541.T>:Says it will start sales of Infliximab BS for I.V. Infusion 100mg "Nichi-Iko" on Nov. 29.  Full Article

Nichi-Iko Pharmaceutical fully buys Sagent Pharmaceuticals, Inc. via takeover bid
Monday, 29 Aug 2016 

Nichi-Iko Pharmaceutical Co Ltd <4541.T>:Says it completed full acquisition of Sagent Pharmaceuticals, Inc. via takeover bid, effective Aug. 29(the U.S. time).  Full Article

Shepard Vision commences all-cash tender offer of $21.75 net per share to buy shares of Sagent
Monday, 1 Aug 2016 

Shepard Vision Inc:Commences all-cash tender offer of $21.75 net per share to acquire all outstanding shares of Sagent Pharmaceuticals, Inc.  Full Article

Sagent Pharma will be required to pay Nichi-Iko Pharma $24.3 mln upon termination of deal
Monday, 11 Jul 2016 

Sagent Pharmaceuticals Inc :Upon termination of deal, under specified circumstances, co will be required to pay Nichi-Iko Pharma termination fee of $24.3 million.  Full Article

Japan's Nichi-Iko to buy Sagent Pharmaceuticals for $21.75 per share in cash
Monday, 11 Jul 2016 

Sagent Pharmaceuticals Inc : Nichi-Iko pharmaceutical Co, Ltd to acquire Sagent Pharmaceuticals for $21.75 per share in all cash transaction . Deal for approximately $736 million . Nichi-Iko intends to finance acquisition through bank loans and available cash .Transaction unanimously approved by Nichi-Iko and Sagent boards of directors.  Full Article

Nichi-Iko Pharmaceutical completes share repurchase
Tuesday, 5 Apr 2016 

Nichi-Iko Pharmaceutical Co Ltd:Completes repurchase of 2,846,800 shares of its common stock, at the price of 7,000,281,200 yen in total, on April 5.  Full Article

Nichi-Iko Pharmaceutical to repurchase shares
Monday, 4 Apr 2016 

Nichi-Iko Pharmaceutical Co Ltd:To repurchase up to 2,846,800 shares, representing a 4.76 pct stake, on April 5.Says share repurchase up to 7,000,281,200 yen in total.  Full Article

Nichi-Iko Pharmaceutical raises consolidated full-year net profit outlook for FY 2016
Tuesday, 9 Feb 2016 

Nichi-Iko Pharmaceutical Co Ltd:Says the company reaffirmed the consolidated full-year outlook for revenue at 140,000 mln yen for the fiscal year ending March 31, 2016.Confirms the operating profit forecast at 12,500 mln yen.Confirms the ordinary profit forecast at 12,100 mln yen.Net profit forecast increased to 11,000 mln yen from 8,000 mln yen.Earnings per share increased to 183.92 yen from 133.77 yen.Says gain from sale of securities as main reason for the forecast.  Full Article